Cornell researchers have identified a switch that regulates inflammation caused by an immune response, a finding that could one day help to control inflammation-related conditions.
A new study provides evidence that a spillover of avian influenza from birds to dairy cattle across several U.S. states has now led to mammal-to-mammal transmission – between cows and from cows to cats and a raccoon.
Kristen Underhill, a professor of law and associate dean for faculty research at Cornell Law School, shares her expertise with learners in the Healthcare Law certificate program from eCornell.
Households in Cambodia caught and consumed a far more diverse array of fish than they sold at market, highlighting how biodiversity loss might affect people’s nutrition, especially for those with lower incomes.
Weill Cornell Medicine has received $4.2 million to study how the immune system in some people infected with HIV can keep the virus under control, which could lead to new therapies.
Researchers at Weill Cornell Medicine have used machine learning to define three subtypes of Parkinson’s disease based on the pace at which the disease progresses.
The newest episode of the Startup Cornell podcast features Jamey Edwards '96 MBA '03, president & chief strategy officer at Koko Home, a company providing radar driven, AI-enabled solutions for healthcare and an Entrepreneur in Residence of StartUp Health, which was founded in 2011 to invest in global health entrepreneurs.
Researchers studying antimicrobial-resistant E. coli – the leading cause of human death due to antimicrobial resistance worldwide – have identified a mechanism in dogs that may render multiple antibiotic classes ineffective.
A new consortium co-led by Weill Cornell Medicine has been awarded a five-year, $31 million grant from the NIH’s National Institute of Allergy and Infectious Diseases to accelerate the development of better treatment regimens for tuberculosis.
